eprintid: 46954
rev_number: 2
eprint_status: archive
userid: 3883
dir: documents_old/00/04/69/54
datestamp: 2021-07-28 17:09:35
lastmod: 2021-09-29 07:42:48
status_changed: 2021-07-28 17:09:35
type: article
metadata_visibility: show
creators_name: Knödler, Maren
creators_name: Körfer, Justus
creators_name: Kunzmann, Volker
creators_name: Trojan, Jörg
creators_name: Daum, Severin
creators_name: Schenk, Michael
creators_name: Kullmann, Frank
creators_name: Schroll, Sebastian
creators_name: Behringer, Dirk
creators_name: Stahl, Michael
creators_name: Al-Batran, Salah-Eddin
creators_name: Hacker, Ulrich
creators_name: Ibach, Stefan
creators_name: Lindhofer, Horst
creators_name: Lordick, Florian
title: Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer
ispublished: pub
full_text_status: none
date_type: published
date_online: 2018
date: 2018
publication: British Journal of Cancer
volume: 119
number: 3
pagerange: 296-302
id_number_name: 10.1038/s41416-018-0150-6
id_number_type: doi
refereed: yes
created_here: yes
issn: 1532-1827
issn: 0007-0920
official_url: http://doi.org/10.1038/s41416-018-0150-6
doi: 10.1038/s41416-018-0150-6
fp7_project: no
fp7_type: info:eu-repo/semantics/article
citation:   Knödler, Maren, Körfer, Justus, Kunzmann, Volker, Trojan, Jörg, Daum, Severin, Schenk, Michael, Kullmann, Frank, Schroll, Sebastian, Behringer, Dirk, Stahl, Michael, Al-Batran, Salah-Eddin, Hacker, Ulrich, Ibach, Stefan, Lindhofer, Horst und Lordick, Florian  (2018) Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer.  British Journal of Cancer 119 (3), S. 296-302.